+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmacokinetics Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Type, Service Type, Therapeutic Application, and End User, and Geography

  • PDF Icon

    Report

  • 174 Pages
  • May 2024
  • Region: Global
  • The Insight Partners
  • ID: 5978804
Description Jump to:
The pharmacokinetics services market size is projected to reach US$1.57 billion by 2031 from US$ 874.96 million in 2023. The market is expected to register a CAGR of 7.6% during 2023-2031.

Market Drivers of the Pharmacokinetics Services Market

Rising Prevalence of Chronic and Infectious Diseases

The growing prevalence of chronic diseases such as diabetes, cancer, and autoimmune diseases has been a prime enabler of drug development efforts across the world. According to the World Health Organization’s (WHO) 2024 data, ~422 million in the world suffer from diabetes, and these cases are mostly found in middle and low-income countries, causing approximately 1.5 million deaths every year. Pharmaceutical companies are at the forefront of developing drugs to treat various diseases. Pharmacokinetic studies are essential for understanding how these drugs behave in a patient’s body by analyzing the process of absorption, distribution, metabolization, and elimination (ADME) within the human body. The absorption of a drug into systemic circulation affects the speed and concentration at which a drug may reach the site of action, e.g., plasma. Drug distribution pattern throughout the body varies based on its biochemical properties and body physiology. Metabolism involves the processing of the drug by the body into subsequent compounds. This step is instrumental in converting the drug into water-soluble substances to render them suitable for renal clearance. Metabolism is also important for the conversion of prodrugs, such as codeine, into active metabolites. Excretion of drugs from the body is mainly governed by kidneys; however, in several cases, drugs may be excreted via the lungs, skin, or gastrointestinal tract. ADME dynamics define the bioavailability of drugs in the body, and the maintenance doses of drugs are calculated based on their clearance times (desired plasma concentration divided by bioavailability). Understanding of clearance allows practitioners to calculate appropriate dosing rates.

Pharmacokinetic studies focus on optimizing drug dose regimens in study subjects to understand the efficacy and safety of a drug. These studies are essential for ensuring the safety of drugs that are developed for long-term treatments, which helps evaluate the suitability and stability of drug formulations in chronic disease management. Hence, the rising burden of chronic and infectious diseases underlines the importance of pharmacokinetic studies to develop safe and effective personalized treatments.

Opportunities in the Pharmacokinetics Services Market

The collection and handling of huge pharmacokinetic data generated during drug manufacturing are expensive, tedious, and time-consuming tasks. The labor- and cost-intensive nature of these tasks highlights the need for models such as pharmacokinetic simulation models and in vitro-in vivo pharmacokinetic correlation models (IVIVC) for the prediction of pharmacokinetic parameters. The pharmacokinetic simulation model is a tool that interprets drug kinetics in the living environment under specific conditions using computational and mathematical models. In addition, the IVIVC model are a fundamental part of the drug discovery process. Analyzing PK/PD predictions at the early stages of drug development is necessary for lead optimization strategies and also to further reduce attrition rates. There have been significant advancements in the development of new in-vitro and in-vivo strategies to improve and characterize pharmacokinetic properties. IVIVC models are being proposed as a cost-effective alternative to assess the biopharmaceutical properties that analyze the bioavailability of drugs and their application. Hence, such in-vivo and in-vitro models are anticipated to provide lucrative opportunities for the pharmacokinetics services market in the near future.

Pharmacokinetics Services Market: Segmental Overview

By drug type, the market is segmented into small molecules, large molecules, and vaccines. The small molecule segment held the largest market share in 2023.

The pharmacokinetics services market, by therapeutic application, is categorized into oncology, infectious diseases, neurological disorders, autoimmune diseases, gynecological disorders, cardiovascular diseases, respiratory disorders, and others. The oncology segment held the largest market share in 2023.

Pharmacokinetics Services Market: Geographical Overview

North America held the largest share of the market. According to a report by the Government of Canada, Health Canada receives hundreds of new clinical trial applications to test new drugs (including vaccines) or to introduce new uses of approved medicines. Pediatric patients (children and youth) in the country participate in clinical trials with their parents’ permission. Health Canada protects individuals participating in clinical trials, including children and youth. According to the Canadian Clinical Trials Asset Map (CCTAM) report, ~3,500 clinical trials were registered in Canada in 2022, with cancer therapeutics being a significant area of focus, accounting for 1,300 cancer clinical trials in 2021. The pharmaceutical industry invested ~US$ 1.2 billion in clinical research in Canada, per the Innovative Medicines Canada report. Further, the Canadian Clinical Trials Network (CCTN) had over 6 million patient records maintained as of 2021. Thus, the demand for pharmacokinetic services increases with the surge in drug development and discovery projects in Canada. Thus, the rising number of clinical trials and research studies, and the increasing prevalence of infectious diseases and chronic disorders are among the factors propelling the pharmacokinetics services market growth in Canada.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pharmacokinetics Services Market Landscape
4.1 PEST Analysis
5. Pharmacokinetics Services Market - Key Market Dynamics
5.1 Pharmacokinetics Services Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Chronic and Infectious Diseases
5.2.2 Expanding Range of Application of Pharmacokinetic Studies
5.2.3 Outsourcing of Pharmacokinetics Services to CROs
5.3 Market Restraints
5.3.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
5.4 Market Opportunities
5.4.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
5.5 Future Trend
5.5.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
5.6 Impact of Drivers and Restraints:
6. Pharmacokinetics Services Market - Global Market Analysis
6.1 Pharmacokinetics Services Market Revenue (US$ Million), 2023-2031
7. Pharmacokinetics Services Market Analysis - by Drug Type
7.1 Overview
7.2 Small Molecule
7.2.1 Overview
7.2.2 Small Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Large Molecule
7.3.1 Overview
7.3.2 Large Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8. Pharmacokinetics Services Market Analysis - by Service Type
8.1 Pre-Clinical ADME and Human Studies
8.1.1 Overview
8.1.2 Pre-Clinical ADME and Human Studies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 PK/PD Analysis and Reporting
8.2.1 Overview
8.2.2 PK/PD Analysis and Reporting: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Dosing Simulations
8.3.1 Overview
8.3.2 Dosing Simulations: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Risk Analysis
8.4.1 Overview
8.4.2 Risk Analysis: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9. Pharmacokinetics Services Market Analysis - by Therapeutic Application
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Infectious Diseases
9.2.1 Overview
9.2.2 Infectious Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Neurological Disorders
9.3.1 Overview
9.3.2 Neurological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Autoimmune Diseases
9.4.1 Overview
9.4.2 Autoimmune Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Gynecological Disorders
9.5.1 Overview
9.5.2 Gynecological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Cardiovascular Diseases
9.6.1 Overview
9.6.2 Cardiovascular Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Respiratory Disorders
9.7.1 Overview
9.7.2 Respiratory Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10. Pharmacokinetics Services Market Analysis - by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Contract Research Organization
10.2.1 Overview
10.2.2 Contract Research Organization: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11. Pharmacokinetics Services Market - Geographical Analysis
11.1 North America
11.1.1 North America Pharmacokinetics Services Market Overview
11.1.2 North America: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
11.1.2.1 United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.1.1 Overview
11.1.2.1.2 United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.1.3 United States: Pharmacokinetics Services Market Breakdown, by Drug Type
11.1.2.1.4 United States: Pharmacokinetics Services Market Breakdown, by Service Type
11.1.2.1.5 United States: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.1.2.1.6 United States: Pharmacokinetics Services Market Breakdown, by End User
11.1.2.2 Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.2.1 Overview
11.1.2.2.2 Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.2.3 Canada: Pharmacokinetics Services Market Breakdown, by Drug Type
11.1.2.2.4 Canada: Pharmacokinetics Services Market Breakdown, by Service Type
11.1.2.2.5 Canada: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.1.2.2.6 Canada: Pharmacokinetics Services Market Breakdown, by End User
11.1.2.3 Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.1.2.3.3 Mexico: Pharmacokinetics Services Market Breakdown, by Drug Type
11.1.2.3.4 Mexico: Pharmacokinetics Services Market Breakdown, by Service Type
11.1.2.3.5 Mexico: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.1.2.3.6 Mexico: Pharmacokinetics Services Market Breakdown, by End User
11.2 Europe
11.2.1 Europe Pharmacokinetics Services Market Overview
11.2.2 Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.3 Pharmacokinetics Services Market Breakdown by Countries
11.2.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
11.2.4.1 Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.1.1 Overview
11.2.4.1.2 Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.1.3 Germany: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.1.4 Germany: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.1.5 Germany: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.1.6 Germany: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.2 France: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.2.1 Overview
11.2.4.2.2 France: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.2.3 France: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.2.4 France: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.2.5 France: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
The market for infectious diseases segment is estimated to be worth US$ 19.24 million by 2031 and is expected to register a CAGR of 10.8% during the 2023-2031.
11.2.4.2.6 France: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.3 United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.3.1 Overview
11.2.4.3.2 United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.3.3 United Kingdom: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.3.4 United Kingdom: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.3.5 United Kingdom: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.3.6 United Kingdom: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.4 Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.4.1 Overview
11.2.4.4.2 Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.4.3 Italy: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.4.4 Italy: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.4.5 Italy: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.4.6 Italy: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.5 Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.5.1 Overview
11.2.4.5.2 Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.5.3 Spain: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.5.4 Spain: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.5.5 Spain: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.5.6 Spain: Pharmacokinetics Services Market Breakdown, by End User
11.2.4.6 Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.6.1 Overview
11.2.4.6.2 Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.2.4.6.3 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Drug Type
11.2.4.6.4 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Service Type
11.2.4.6.5 Rest of Europe: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.2.4.6.6 Rest of Europe: Pharmacokinetics Services Market Breakdown, by End User
11.3 Asia Pacific
11.3.1 Asia Pacific Pharmacokinetics Services Market Overview
11.3.2 Asia Pacific: Pharmacokinetics Services Market
11.3.3 Asia Pacific: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
11.3.3.1 China: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.1 Overview
11.3.3.1.2 China: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.1.3 China: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.1.4 China: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.1.5 China: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.1.6 China: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.2 Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.1 Overview
11.3.3.2.2 Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.2.3 Japan: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.2.4 Japan: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.2.5 Japan: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.2.6 Japan: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.3 India: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.1 Overview
11.3.3.3.2 India: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.3.3 India: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.3.4 India: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.3.5 India: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.3.6 India: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.4 Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.1 Overview
11.3.3.4.2 Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.4.3 Australia: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.4.4 Australia: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.4.5 Australia: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.4.6 Australia: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.5 South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.1 Overview
11.3.3.5.2 South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.5.3 South Korea: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.5.4 South Korea: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.5.5 South Korea: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.5.6 South Korea: Pharmacokinetics Services Market Breakdown, by End User
11.3.3.6 Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.1 Overview
11.3.3.6.2 Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.3.3.6.3 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Drug Type
11.3.3.6.4 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Service Type
11.3.3.6.5 Rest of APAC: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.3.3.6.6 Rest of APAC: Pharmacokinetics Services Market Breakdown, by End User
11.4 Middle East and Africa
11.4.1 Middle East and Africa Pharmacokinetics Services Market Overview
11.4.2 Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.3 Pharmacokinetics Services Market Breakdown by Countries
11.4.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
11.4.5 Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast Analysis - by Country
11.4.5.1 Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.1.1 Overview
11.4.5.1.2 Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.1.3 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.1.4 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.1.5 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.1.6 Saudi Arabia: Pharmacokinetics Services Market Breakdown, by End User
11.4.5.2 South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.2.1 Overview
11.4.5.2.2 South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.2.3 South Africa: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.2.4 South Africa: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.2.5 South Africa: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.2.6 South Africa: Pharmacokinetics Services Market Breakdown, by End User
11.4.5.3 United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.3.1 Overview
11.4.5.3.2 United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.3.3 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.3.4 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.3.5 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.3.6 United Arab Emirates: Pharmacokinetics Services Market Breakdown, by End User
11.4.5.4 Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.4.1 Overview
11.4.5.4.2 Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.4.5.4.3 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Drug Type
11.4.5.4.4 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Service Type
11.4.5.4.5 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.4.5.4.6 Rest of Middle East and Africa: Pharmacokinetics Services Market Breakdown, by End User
11.5 South and Central America
11.5.1 South and Central America Pharmacokinetics Services Market Overview
11.5.2 South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.3 Pharmacokinetics Services Market Breakdown by Countries
11.5.4 Pharmacokinetics Services Market Revenue and Forecast and Analysis - by Country
11.5.4.1 Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.1.1 Overview
11.5.4.1.2 Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.1.3 Brazil: Pharmacokinetics Services Market Breakdown, by Drug Type
11.5.4.1.4 Brazil: Pharmacokinetics Services Market Breakdown, by Service Type
11.5.4.1.5 Brazil: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.5.4.1.6 Brazil: Pharmacokinetics Services Market Breakdown, by End User
11.5.4.2 Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.2.1 Overview
11.5.4.2.2 Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.2.3 Argentina: Pharmacokinetics Services Market Breakdown, by Drug Type
11.5.4.2.4 Argentina: Pharmacokinetics Services Market Breakdown, by Service Type
11.5.4.2.5 Argentina: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.5.4.2.6 Argentina: Pharmacokinetics Services Market Breakdown, by End User
11.5.4.3 Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.3.1 Overview
11.5.4.3.2 Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
11.5.4.3.3 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Drug Type
11.5.4.3.4 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Service Type
11.5.4.3.5 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by Therapeutic Application
11.5.4.3.6 Rest of South and Central America: Pharmacokinetics Services Market Breakdown, by End User
12. Company Profile
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eurofins Scientific SE
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Certara Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.5 Parexel International Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Allucent
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PACIFIC BIOLABS
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SGS SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Shanghai Medicilon Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
List of Tables
Table 1. Pharmacokinetics Services Market Segmentation
Table 2. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 3. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 4. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 5. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 6. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 7. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 8. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 9. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 10. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 11. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 12. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 13. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 14. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 15. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 16. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 17. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 19. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 20. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 21. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 22. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 23. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 24. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 25. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 27. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 28. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 29. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 30. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 31. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 32. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 33. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 34. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 35. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 36. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 37. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 38. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 39. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 40. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 41. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 42. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 43. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 44. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 45. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 46. R&D Expenditure of Indian Companies, 2018-2020 (US$ Million)
Table 47. Company
Table 48. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 49. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 50. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 51. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 52. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 53. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 54. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 55. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 56. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 57. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 58. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 59. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 60. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 61. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 62. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 63. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 64. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 65. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 66. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 67. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 68. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 69. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 70. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 71. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 72. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 73. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 74. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 75. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 76. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 77. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 78. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 79. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 80. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 81. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 82. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 83. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 84. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 85. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 86. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 87. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 88. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Drug Type
Table 89. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Service Type
Table 90. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Application
Table 91. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million) - by End User
List of Figures
Figure 1. Pharmacokinetics Services Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Pharmacokinetics Services Market Revenue (US$ Million), 2023-2031
Figure 5. Pharmacokinetics Services Market, By Geography Forecast Analysis, 2023 & 2031
Figure 6. Pharmacokinetics Services Market Share (%) - by Drug Type (2023 and 2031)
Figure 7. Small Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Large Molecule: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Vaccines: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pharmacokinetics Services Market Share (%) - by Service Type (2023 and 2031)
Figure 11. Pre-Clinical ADME and Human Studies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. PK/PD Analysis and Reporting: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Dosing Simulations: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Risk Analysis: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pharmacokinetics Services Market Share (%) - by Therapeutic Application (2023 and 2031)
Figure 17. Oncology: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Infectious Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Neurological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Autoimmune Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Gynecological Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Cardiovascular Diseases: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Respiratory Disorders: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Pharmacokinetics Services Market Share (%) - by End User (2023 and 2031)
Figure 26. Pharmaceutical and Biotechnology Companies: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Contract Research Organization: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Pharmacokinetics Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. North America: Pharmacokinetics Services Market by Key Countries - Revenue (2023) US$ Million
Figure 30. North America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. North America: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 32. United States: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Canada: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Mexico: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Europe: Pharmacokinetics Services Market - Revenue by Key Countries Revenue 2023 (US$ Million)
Figure 36. Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 37. Europe: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 38. Germany: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. France: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. United Kingdom: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Italy: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. Spain: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Rest of Europe: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Asia Pacific: Pharmacokinetics Services Market - Revenue by Key Countries 2023 (US$ Million)
Figure 45. Asia Pacific: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 47. China: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 48. Japan: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 49. India: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 50. Australia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 51. South Korea: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. Rest of APAC: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Middle East and Africa: Pharmacokinetics Services Market by Key Countries - Revenue 2023 (US$ Million)
Figure 54. Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 55. Pharmacokinetics Services Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 56. Middle East and Africa: Pharmacokinetics Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 57. Saudi Arabia: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 58. South Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 59. United Arab Emirates: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 60. Rest of Middle East and Africa: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 61. South and Central America: Pharmacokinetics Services Market by Key Countries - Revenue 2023 (US$ Million)
Figure 62. South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 63. Pharmacokinetics Services Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 64. Brazil: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 65. Argentina: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 66. Rest of South and Central America: Pharmacokinetics Services Market - Revenue and Forecast to 2031(US$ Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Charles River Laboratories International Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Certara Inc.
  • Parexel International Corp
  • Thermo Fisher Scientific Inc.
  • Allucent
  • PACIFIC BIOLABS
  • SGS SA
  • Shanghai Medicilon Inc.

Table Information

Report AttributeDetails
No. of Pages174
PublishedMay 2024
Forecast Period2023 - 2031
Estimated Market Value ( USD ) in 2023 $ 874.96 Million
Forecasted Market Value ( USD ) by 2031 $ 1579.8 Million
Compound Annual Growth Rate7.6%
Regions CoveredGlobal

Related Topics

Related Reports

Pharmacokinetics Services - Global Strategic Business Report - Product Image

Pharmacokinetics Services - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Global Pharmacokinetics Services Market by Type (Large Molecules Pharmacokinetics Services, Small Molecules Pharmacokinetics Services), Application (Large Enterprise, Small and Medium Enterprise) - Forecast 2024-2030 - Product Image

Global Pharmacokinetics Services Market by Type (Large Molecules Pharmacokinetics Services, Small Molecules Pharmacokinetics Services), Application (Large Enterprise, Small and Medium Enterprise) - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use (Biotechnology & Pharmaceutical Companies) By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use (Biotechnology & Pharmaceutical Companies) By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 110 Pages
  • Global
From
Pharmacokinetics Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Pharmacokinetics Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Pharmacokinetics Service Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Pharmacokinetics Service Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 98 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.